Results 211 to 220 of about 123,214 (256)

Reframing the role of glucagon‐like peptide 1 receptor agonists in cardiovascular medicine

ESC Heart Failure, Volume 12, Issue 2, Page 923-926, April 2025.
Riccardo M. Inciardi, Alvin Chandra, Ambarish Pandey, Marco Metra   +3 more
wiley   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Management of Heart Failure With Reduced Ejection Fraction

Current Problems in Cardiology, 2023
Heart failure with reduced ejection fraction (HFrEF) is a complex and progressive clinical condition characterized by dyspnea and functional impairment. HFrEF has a high burden of mortality and readmission rate making it one of the most significant public health challenges.
Ahmed Mustafa Rashid, Muhammad Shahzeb Khan, Marat Fudim, Tracy A. DeWald, Adam DeVore, Javed Butler   +5 more
openaire   +2 more sources

Heart Failure Without a Reduced Ejection Fraction

The American Journal of Managed Care, 2023
Heart failure (HF) substantially impacts the health and financial security of an increasing proportion of the US population. It worsens debility and quality of life and may lead to hospitalization and death. HF is a clinical syndrome with diverse symptomatic presentations.
Sant, Kumar, Mitchell A, Psotka
openaire   +2 more sources

Heart Failure With Reduced Ejection Fraction

JAMA, 2020
Worldwide, the burden of heart failure has increased to an estimated 23 million people, and approximately 50% of cases are HF with reduced ejection fraction (HFrEF).Heart failure is a clinical syndrome characterized by dyspnea or exertional limitation due to impairment of ventricular filling or ejection of blood or both.
Sean P, Murphy, Nasrien E, Ibrahim, James L, Januzzi   +2 more
openaire   +2 more sources